Extracellular miRNAs: from biomarkers to mediators of physiology and disease

MA Mori, RG Ludwig, R Garcia-Martin, BB Brandão… - Cell metabolism, 2019 - cell.com
miRNAs can be found in serum and other body fluids and serve as biomarkers for disease.
More importantly, secreted miRNAs, especially those in extracellular vesicles (EVs) such as …

Macrophage death as a pharmacological target in atherosclerosis

W Martinet, I Coornaert, P Puylaert… - Frontiers in …, 2019 - frontiersin.org
Atherosclerosis is a chronic inflammatory disorder characterized by the gradual build-up of
plaques within the vessel wall of middle-sized and large arteries. Over the past decades …

Imaging residual inflammatory cardiovascular risk

C Antoniades, AS Antonopoulos… - European Heart …, 2020 - academic.oup.com
Targeting residual cardiovascular risk in primary and secondary prevention, would allow
deployment of novel therapeutic agents, facilitating precision medicine. For example …

Circulating microRNA signatures associated with disease severity and outcome in COVID-19 patients

A Giannella, S Riccetti, A Sinigaglia, C Piubelli… - Frontiers in …, 2022 - frontiersin.org
Background SARS-CoV-2 induces a spectrum of clinical conditions ranging from
asymptomatic infection to life threatening severe disease. Host microRNAs have been …

Endothelial cells: from dysfunction mechanism to pharmacological effect in cardiovascular disease

H Haybar, S Shahrabi, H Rezaeeyan, R Shirzad… - Cardiovascular …, 2019 - Springer
Endothelial cells (ECs) are the innermost layer of blood vessels that play important roles in
homeostasis and vascular function. However, recent evidence suggests that the onset of …

MicroRNA-30c-5p inhibits NLRP3 inflammasome-mediated endothelial cell pyroptosis through FOXO3 down-regulation in atherosclerosis

P Li, X Zhong, J Li, H Liu, X Ma, R He, Y Zhao - … and biophysical research …, 2018 - Elsevier
Atherosclerosis is a chronic inflammatory disease involved in endothelial dysfunction.
Pyroptosis is a pro-inflammatory form of cell death and plays pivotal roles in atherosclerosis …

Overexpression of MicroRNA‐16 Alleviates Atherosclerosis by Inhibition of Inflammatory Pathways

M Wang, J Li, J Cai, L Cheng, X Wang… - BioMed Research …, 2020 - Wiley Online Library
Background. Our previous study demonstrated that the expression of miR‐16 was
downregulated in the cell and animal models of atherosclerosis (AS), a main contributor to …

MicroRNAs: Key modulators of inflammation-associated diseases

B Chatterjee, M Sarkar, S Bose, MT Alam… - Seminars in Cell & …, 2024 - Elsevier
Inflammation is a multifaceted biological and pathophysiological response to injuries,
infections, toxins, and inflammatory mechanisms that plays a central role in the progression …

[HTML][HTML] Circulating extracellular vesicles and small non-coding RNAs cargo in idiopathic inflammatory myopathies reveal differences across myositis subsets

C Franco, A Giannella, M Gasparotto, E Zanatta… - Journal of …, 2024 - Elsevier
Objective To investigate the epigenetic footprint of idiopathic inflammatory myopathies (IIM)
through characterization of circulating extracellular vesicles (EVs) and the expression of EV …

Immune and central nervous system-related miRNAs expression profiling in monocytes of multiple sclerosis patients

A Amoruso, M Blonda, M Gironi, R Grasso… - Scientific Reports, 2020 - nature.com
It is widely recognized that monocytes-macrophages adopt a wide variety of phenotypes,
influencing the inflammatory activity and demyelination in Multiple Sclerosis (MS). However …